Vaccine Therapy in Non-Small Cell Lung Cancer

Immunotherapy using immune checkpoint modulators has revolutionized the oncology field, emerging as a new standard of care for multiple indications, including non-small cell lung cancer (NSCLC). However, prognosis for patients with lung cancer is still poor. Although immunotherapy is highly effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Pardo, Miguel, Gorria, Teresa, Malenica, Ines, Corgnac, Stéphanie, Teixidó, Cristina, Mezquita, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146850/
https://www.ncbi.nlm.nih.gov/pubmed/35632496
http://dx.doi.org/10.3390/vaccines10050740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146850/
https://www.ncbi.nlm.nih.gov/pubmed/35632496
http://dx.doi.org/10.3390/vaccines10050740

Ejemplares similares